Black Rock Inc. Pacira Bio Sciences, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,006,826 shares of PCRX stock, worth $199 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,006,826
Previous 7,905,156
1.29%
Holding current value
$199 Million
Previous $231 Million
0.83%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding PCRX
# of Institutions
255Shares Held
51.4MCall Options Held
289KPut Options Held
130K-
Vanguard Group Inc Valley Forge, PA5.41MShares$134 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$59.4 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$55.9 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$53.4 Million0.01% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.13MShares$52.9 Million0.08% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.14B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...